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Abstract: Background: Liver transplantation is the optimal method of treatment in patients with end-stage liver failure. 
Transplantation medicine has significantly progressed in the last time, but some psychology and psychosomatic problems 
still remain unsolved. Health-Related Quality of Life (HRQL) in liver transplant is considered a useful measure of evolu-
tionary process of the illness.  
Objective: The authors analyzed the evolution of HRQL in pre-transplant (waiting-list patients) and post-transplant (first 
year after liver transplant) periods of liver transplant Spanish patients.  
Methods: A prospective and longitudinal study was carried out among patients who received a liver transplant from a de-
ceased donor. They were assessed in four phases: at the time of inclusion on the transplant waiting-list, and 3, 6, and 12 
months after receiving the graft. We used a structured interview and SF-36 and Euroqol-5D (EQ-5D) Health Questionnaires.  
Results: The greater differences were found between pre-transplant and post-transplant stages with less well-being in the 
stage before the transplant. No significantly differences were observed when comparing the 3, 6 and 12 months from post-
transplant stage.  
Conclusion: The HQRL of liver patients improved after the transplant, being appreciated a tendency to the stabilization 
from three months onwards. We suggest that the psychological intervention, in liver patients, should be conducted in wait-
ing-list patients and in the first 3 months post-transplant, periods with a poor mental health (anxiety, depression, and stress 
by fear to the unknown thing) and a low adhesion to the treatment that can generate a smaller graft and/or patient survival.  
Keywords: Health-related quality of life, Liver transplant, Pre- and post-transplant stages. 
INTRODUCTION 
Liver transplant has evolved from experimental treatment 
to standard treatment for all patients with progressive and 
irreversible hepatobiliary disease. Although their success has 
been measured by patient and graft survival, this kind of 
interventions can lead to very diverse conditions, ranging 
from recovery of "near” normality to a condition of charac-
teristics that are similar to chronicity, with a broad array of 
deficits and impairments [1]. In this sense, some of the psy-
chological complications that emerge after transplant are 
mood disorders, anxiety disorders, sexual disorders, fantasies 
about the donor, and dissatisfaction with body image [2]. 
Consequently, some time after transplant surgery, all of this 
leads patients to become more concerned about their quality 
of life than their longevity [3]. In this context, Health-
Related Quality of Life (HRQL) becomes more relevant; it is 
a multidimensional construct that includes three essential 
domains (physical, psychological, and social functioning), 
which may be affected by the disease and/or by treatment [4-
6]. 
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Most studies of this topic conclude that liver transplant 
leads to an improvement in patients' quality of life, which 
approaches but does not reach that of the general population 
[7-11]. For example, Pantiga et al. [12] studied HRQL in 
three different groups: patients with cirrhosis who presented 
three levels of severity (mild, moderate, and severe), trans-
planted patients, and healthy subjects. The results showed 
that the quality of life of the transplanted patients did not 
reach the levels of the healthy population, although it was 
significantly better than that of the patients with cirrhosis, 
especially those who were at advanced stages. Along these 
same lines, other studies that compare groups of sick trans-
plant candidates, liver transplanted patients, and healthy sub-
jects also found better functioning in the healthy people and 
worse in the transplant candidates. In comparison with the 
last group, the liver transplanted patients had fewer limita-
tions in their psychosocial functioning, but in comparison 
with the control subjects, some aspects of their functioning 
were worse, especially in the physical and social domains 
[13]. 
Regarding the evolution of HRQL after liver transplant, 
investigations that establish different comparison time inter-
vals after the graft are particularly interesting. So, for exam-
ple, Bona et al. [14] found that patients' quality of life in-
creased during the first 6 months after transplant, it de-
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creased in the 13-to-24-month time interval due to difficul-
ties adapting to sociowork conditions, and improved between 
3 and 5 years after the transplant, when the patients achieved 
new emotional stability. In another study in which different 
temporal moments were compared, Ratcliffe et al. [15] 
found a significant improvement in HRQL 3 months after 
transplant, but at subsequent follow-ups (6, 12, and 24 
months), although the perception of physical well-being con-
tinued to improve, the score referring to mood had not 
changed. Some investigations conclude that patients reach a 
degree of normality 12 months after transplant [16], whereas 
other studies consider that these patients have constant health 
problems because of the side effects of the immunosupressor 
treatment [17, 18]. 
On the basis of these works, we can conclude that after 
liver transplant, patients' HRQL is not stable, but instead 
different phases are observed, some better and some worse. 
It all depends on the temporal intervals that are compared 
and which are different in the diverse investigations. Given 
the relevance of this topic, in this research, our main goal is 
to analyze the evolution of HRQL in liver transplanted pa-
tients, taking into account four temporal moments: pre-
transplant phase (the moment the patient is included on the 
transplant waiting-list) and post-transplant phase (3, 6, and 
12 months after receiving the graft). 
METHODS 
Context 
This work was carried out in the University Hospital 
Virgen del Rocío, a hospital of reference in transplant to 
National level, and inside of a thematic network of trans-
plants in all country. It is emphasized that each center, only 
is authorized to publish its own data and that this is the first 
time that is done a study of these characteristics in Spain. 
Subjects 
We selected a group of 27 Spanish patients (19 men and 
8 women, with mean age of 51.67 years), with a cultural and 
economic state of middle-low, who received a first liver 
transplant from a person who had died at the Hospital Virgen 
del Rocío of Seville (Table 1). Strict confidentiality was en-
sured. The etiology of the different illnesses was: alcoholic 
cirrhosis (30.8%), hepatitis C virus (26.9%), hepatocarci-
noma (15.3%), hepatitis B virus (3.8%) and others (23.2%). 
The time on the waiting-list was an average of 225.08 days. 
All selected patients for the study possessed a severity of 
their liver diseases of serious in Child’s Pugh, this did them 
patients of high priority for the transplant. 
As general characteristics taken into account when select-
ing the patients, there were four inclusion criteria: 1) they 
were 18 years old or older at the moment of their inclusion 
on the transplant waiting-list, 2) they had sufficient cognitive 
capacity to complete the questionnaires, 3) they were in-
cluded on the waiting-list to receive a first liver transplant 
(re-transplanted patients and cases with extreme urgency 
were excluded), and 4) they gave their written informed con-
sent to participate in the study. Finally, they were excluded 
of study those patients that died previously to receive liver 
transplant. 
Study Design 
The liver transplanted patients were assessed in four 
stages: at the time of inclusion on the waiting-list for the 
transplant, at 3, 6, and 12 months after receiving the graft. 
Firstly, once patients were on the waiting-list, after providing 
them with information about the research and clearing up all 
their doubts, they were asked to collaborate voluntarily and 
to give their written informed consent. Secondly, a structured 
interview was administered, in which diverse sociode-
mographic and clinical data were collected. Thirdly, by 
means of two questionnaires and at the four temporal mo-
ments of this research, we assessed HRQL. The data were 
collected during the interval from October 2003 until June 
2006.  
Outcome Measures 
Structured interview: made up of three blocks: 1) general 
data: age, sex, weight, height, etc., 2) sociodemographic 
data: level of income, educational level, work situation, etc., 
3) clinical data: these were requested from the patients' doc-
tor and referred to very diverse areas such as general antece-
dents (consumption of tobacco and alcohol, arterial hyper-
tension, dyslipidema, diabetes, and Chronic Obstructive 
Pulmonary Disease, etiology of the liver disorder (ethylic, 
hepatitis B, hepatitis C, tumor, cryptogenic, hemochromato-
sis, etc.), date of inclusion on the waiting-list, Child-Pugh 
classification (mild, moderate, and severe), MELD (Model 
End-stage Liver Disease) classification, number of crises of 
acute rejection, laboratory data (hemoglobin, triglycerides, 
alkaline phosphatase, total bilirubin, time and rate of 
prothrombin, ascites, encephalopathy, etc.), type of immuno-
suppressor treatment for the transplant (cyclosporine, tac-
rolimus, sirolimus, mycophenolate mofetil, etc.), and number 
and duration of hospital admittances. Some clinical data 
were obtained directly in the first phase of the study (wait-
Table 1. Demographic and Social Characteristics of the  
Patients Included in the Study 
 N= 27  
Average age  51,67 
Male  19 (70,3%) 
Female  8 (29,6%) 
Educational level  Low-middle 
Marital status   
Married  16 (59,2%) 
Divorced/separated  6 (22,2%) 
Widowed  2 (7,4%) 
Single  3 (11,1%) 
Work   
Yes  10 (37%) 
No  5 (18,5%) 
Retired  12 (44,4%) 
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ing-list) and others at the protocol follow-up performed with 
these patients (3, 6, and 12 months after the graft). 
SF-36 Health Survey [19]: this is made up of 36 items, 
each one with various response alternatives that provide a 
health status profile. The test explores eight dimensions: 
“physical functioning”, “role limitations due to physical 
problems”, “body pain", "general health", "vitality", "social 
functioning", “role limitations due to emotional problems”, 
and "mental health". In each dimension, a score ranging from 
0 (worse health status) to 100 (better health status) is ob-
tained. Alonso et al. [19] studied the characteristics of reli-
ability and validity of this test in Spanish population and 
found that the measures for internal reliability (Cronbach's 
alpha) of the different categories ranged between 0.45 and 
0.94, with a mean value of 0.78, and always above the value 
of 0.70, except for the dimension “social functioning" which 
did not exceed 0.45. For test-retest reliability, the correlation 
coefficients ranged between 0.51 and 0.85. 
Euroqol 5-D (EQ-5D) Health Questionnaire [20]: this is 
a descriptive system of health status with five dimensions: 
“mobility”, “self care”, “daily living activities”, “pain/dis- 
comfort”, and "anxiety/depression”. Each dimension has 3 
items, which define three levels of severity: from 1 (better 
quality of life) to 3 (worse quality of life). Moreover, it in-
cludes a self-appraisal health status thermometer or analogic 
visual scale, the scores of which range between 0 (worst pos-
sible health status) and 100 (best possible health status). 
Test-retest reliability ranged between 0.86 and 0.90 [21], and 
regarding validity, the correlation with the SF-36 is satisfac-
tory, except for the area of “psychological functioning 
status” [22].  
Ethical Considerations 
Ethical approval for the study was obtained from the 
ethical committee of the University Hospital Virgen del 
Rocío of Seville. All patients were asked to sign an informed 
consent form. 
Data Analysis 
All the analyses were performed with the SPSS statistical 
package for social science V16.0. In order to analyze the 
evolution of HRQL in the transplanted patients, we com-
pared the different dimensions assessed by the question-
naires employed in this study at four temporal moments: 
moment of inclusion of patients on transplant waiting-list, 
and at 3, 6, and 12 months after having received the graft. 
For this purpose, firstly, we conducted repeated measures 
analysis of variance and, secondly, in the dimensions that 
were significant (P < 0.05), in order to determine between 
which temporal moments there were differences, we per-
formed a posteriori comparisons (pair comparisons between 
the levels of the time factor). In addition, to control the rate 
of error, both the critical levels and the confidence intervals 
were adjusted by means of Bonferroni’s correction.  
3. RESULTS 
As can be seen in Tables 2 and 3, when comparing the 
phases of this study, all the dimensions that were assessed by 
the two questionnaires were statistically significant. The pa-
Table 2. Specific Data of the Evolution of HRQL (SF-36) in Liver Transplanted Patients. Scores Range Between 0 and 100. Higher 
Scores Represent Better HRQL.* p <0 .05, ** p < 0.01. 
Post-transplant phase Comparisons of phases (p) 
SF-36 
Phase 
pre-
transplant 
(n=27) 
3 
months 
(n=27) 
6 
months 
(n=27) 
12 
months 
(n=27) 
p 
Pre-3 
month 
Pre-6 
month 
Pre-12 
month 
3-6 
months 
3-12 
months 
6-12 
months 
Physical function-
ing 
31.66 62.40 66.48 73.88 0.000** 0.000** 0.000** 0.000** 1,000 0.172 0.262 
Role limitations 
due to physical 
problems 
9.25 40.55 45.74 57.68 0.000** 0.004** 0.000** 0.000** 1,000 0.449 1,000 
Body pain 65.18 83.98 78.14 74.81 0.014* 0.007** 0.127 0.402 1,000 0.231 1,000 
General health 26.11 44.44 42.40 48.33 0.002** 0.003** 0.009** 0.003** 1,000 1,000 1,000 
Vitality 25.07 62.40 61.48 59.25 0.000** 0.000** 0.000** 0.000** 1,000 1,000 1,000 
Social functioning 40.74 72.22 68.05 69.90 0.000** 0.000** 0.004** 0.000** 1,000 1,000 1,000 
Role limitations 
due to emotional 
problems 
35.06 77.77 70.37 69.44 0.021* 0.009** 0.094 0.071 1,000 1,000 1,000 
Mental health  50.40 75.40 73.11 69.62 0.002** 0.001** 0.002** 0.027* 1,000 1,000 1,000 
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tients displayed less well-being in the stage before the trans-
plant (waiting-list) in the physical, psychological, and social 
areas, observing an important improvement with a tendency 
to stabilize 3 months after receiving the transplant. 
In the case of the SF-36, Fig. (1), upon comparing the 
pre-transplant phase with the 3-month post-transplant phase, 
significant improvement was observed at this second phase 
in the eight dimensions assessed. This same tendency was 
observed when comparing the pre-transplant phase with the 
6- and 12-month post-transplant phases, except for the di-
mensions “body pain" and “role limitations due to emotional 
problems”, where there were no significant differences. No 
statistically significant differences were observed in any of 
the dimensions assessed with the SF-36 when comparing the 
3-month phase with the 6- and 12-month phases, or when 
comparing the latter two temporal intervals. 
With regard to the Euroqol (EQ-5D), Figs. (2 and 3), 
when comparing the pre-transplant phase with the 3-month 
post-transplant interval, significant improvement was ob-
served in all the dimensions except for the dimension “self 
care”. Likewise, this tendency was observed in all the di-
mensions when comparing the pre-transplant phase with the 
6-month post-transplant phase. In the comparison of the pre-
transplant phase with the 12-month follow-up, there was 
significant improvement in all the dimensions except for 
“anxiety-depression”. There were no statistically significant 
differences in any of the dimensions assessed with the Euro-
qol when comparing the 3-month phases with the 6- and 12-
month phases after the transplant, or when comparing the 
latter two temporal moments. 
DISCUSSION 
After analyzing the results, we found that the patients had 
lower physical, psychological, and social well-being in the 
waiting-list phase, probably due to the fact that, at the stage 
immediately prior to transplant, patients usually experience 
Table 3. Specific Data of the Evolution of HRQL (EUROQOL-5D) in Liver Transplanted Patients. In the First Five Dimensions, 
whose Scores Range Between 1 and 3, Higher Scores Represent Worse HRQL. In the Last Dimension, whose Score 
Ranges Between 0 and 100, Higher Scores Represent Better HRQL. * p <0 .05, ** p <0 .01. 
Post-transplant phase Comparisons of phases (p) 
EUROQOL-5D 
Phase pre-
transplant 
(n=27) 
3 
months 
(n=27) 
6 
months 
(n=27) 
12 
months 
(n=27) 
p 
Pre-3 
month 
Pre-6 
month 
Pre-12 
month 
3 - 6 
months 
3-12 
months 
6-12 
months 
Mobility 1.59 1.19 1.11 1.11 0.018* 0.016* 0.008** 0.008** 1,000 0.967 1,000 
Self care 1.41 1.15 1.04 1.07 0.004** 0.192 0.004** 0.008** 0.498 1,000 1,000 
Daily living activities 2.26 1.67 1.52 1.56 0.000** 0.007** 0.000** 0.000** 1,000 1,000 1,000 
Pain/discomfort 2.04 1.44 1.48 1.56 0.000** 0.000** 0.002** 0.001** 1,000 1,000 1,000 
Anxiety/depression 1.85 1.26 1.30 1.41 0.002** 0.002** 0.002** 0.093 1,000 0.967 1,000 
Current health 34.26 73.52 67.78 69.63 0.000** 0.000** 0.000** 0.000** 0.390 1,000 1,000 
 
 
Fig. (1). Graphic representation of the evolution of HRQOL (SF-36) in liver transplanted patients. 
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the typical symptoms of cirrhosis to some degree. Similar 
results were obtained by Burgos et al. [23], who also found 
that the patients displayed worse quality of life in the pre-
transplant phase, improving significantly after transplant, 
regardless of the post-transplant interval. 
When comparing the pre-transplant phase (when the pa-
tient is on the waiting-list) and the post-transplant phase (3, 
6, and 12 months after the transplant), patients showed a 
significant improvement that was more pronounced at the 
first post-transplant moments. Among others, the causes of 
their worse HRQL in the waiting-list phase lie in the fact that 
this stage is full of uncertainty and is associated with a high 
degree of morbidity and mortality, feelings of loss of free-
dom because patients must be located 24 hours a day, it is 
impossible to know how long they must wait until receiving 
a transplant, and the high level of anxiety caused by thinking 
about how they must enter an operating room to undergo a 
high-risk surgical intervention [24-26]. It should be taken 
into account that, after the transplant, the patients enjoy more 
physical independence because their health status improves, 
and this allows them to return to their daily activities and 
thus become integrated in their social, work, and family 
spheres; all of this has a positive impact on their physical, 
psychological, and social well-being during the diverse post-
transplant phases. 
When focusing on the dimensions that improved after the 
transplant, it must be taken into account that, in comparison 
with the pre-transplant phase, as time passes, there are fewer 
areas in which the patients presented a significant improve-
ment. Specifically, of the 14 dimensions assessed in this 
study, the patients experienced an improvement at the begin-
ning (3-month post-transplant) in 13 dimensions, subse-
quently (6-month post-transplant) in 12, and lastly (12-
month post-transplant) in 11 dimensions. This means that 
although HRQL improves after transplant in comparison 
with the pre-transplant phase, one year after surgery, three 
dimensions are firmly fixed: "body pain", “role limitations 
due to emotional problems”, and “anxiety-depression”. The 
findings of Sargent et al. [27], who also found less im-
provement in the psychological dimensions, point in the 
same direction. A possible explanation is that sometimes 
patients have excessively optimistic expectations about the 
transplant (they do not expect any medical or psychological 
complication), so that immediately after the transplant, these 
expectations are not met, especially if we take into account 
that all immunosupressor medications are associated with a 
list of adverse side effects such as general toxicity (hirsu-
tism, gingivitis, diarrhea, osteoporosis, neurotoxicity, neph-
rotoxicity, arterial hypertension, diabetes mellitus, hyperlipi-
demia) and toxicity due to immunodepression (infections, de 
 
Fig. (2). Graphic representation of the evolution of HRQOL (EUROQOL-5D) in liver transplanted patients. 
 
Fig. (3). Graphic representation of the evolution of "Current health" (EUROQOL-5D) in liver transplanted patients. 
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novo tumors) [28]. These sequelae are very disturbing for the 
patients, even to the point of limiting their improvement pro-
duced by the transplant [29, 30]. This causes a great amount 
of disappointment in the transplanted patients, and some of 
them even think that they have exchanged their deteriorated 
health status for a similar status, and this has a negative im-
pact on their mood [15, 16]. In this context, it must be taken 
into account that transplanted patients usually receive a lot of 
information about the surgical procedure and pre-operative 
preparation, but little information about the adverse effects 
of the immunosupressor treatment [31]. 
However, as of 3 months, a tendency toward stabilization 
is observed in all the dimensions assessed, that is, whereas 
there are significant differences when comparing the pre-
transplant phase with the diverse post-transplant phases, 
these differences do not appear when comparing the 3-to-6-
month, the 3-to-12-month, and the 6-to-12-month periods. 
This means that, in the case of liver transplanted patients, 
HRQL stabilizes as of 3 months, that is, from that time on, 
patients' physical, psychological, and social well-being nei-
ther improves nor worsens, it simply remains stable. One 
could say that, as of 3 months, the patients adapt to all the 
circumstances involved in the transplant: they become used 
to the therapeutic prescriptions, they rejoin their sociowork 
environment, they stop fearing rejection of the organ, and 
they find more support from their family, because the family 
has recovered psychologically from the initial emotional 
impact of the transplant [32, 33]. It is indicated here, that 
although the sample size was small, the answer was univer-
sal in all the cases, indistinctly to illness type that conducted 
the patients to the liver transplant.  
Nevertheless, it must be remembered that liver transplan-
tation is a complex process that requires a multidisciplinary 
intervention to achieve maximum HRQL in the patients, and 
psychological support (techniques of relaxation, training in 
social abilities, activities of distraction, program psycho-
educational and groups of self-help) is particularly necessary 
in the pre-transplant phase and in the first 3 months post-
transplant because that is when the patients show most 
physical and psychological deterioration. 
Limitations and Future Perspectives 
Liver transplantation not only improves length of life, but 
also significantly improves the quality of life of patients with 
end-stage liver disease. The majority of studies have re-
ported this information, but failed to provide a longitudinal 
assessment that have included measures of utility of HRQL 
for both the pretransplantation and posttransplantation peri-
ods. In this way, would be recommendable for future re-
searchs: A) Studying the influence that performs, in the qual-
ity of life of transplanted patients, some medical variables 
such as, pre-transplant (disease etiology that caused the 
transplant), peri- transplant (quality of the transplanted graft) 
and post- transplant (immunosuppressant types employed). 
B) Using specific instruments to evaluate the quality of life, 
that report of the liver illness symptoms as for example en-
cephalopathy episodes, liver illness effects in the daily ac-
tivities, concentration and memory problems, etc. 
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